Delivery Order SPE2DB24D8002-SPE2DB25FJNFU
Award Date
3/4/25
Potential Completion Date
3/5/25
Potential Value
$23K
Federal Agency
Defense Logistics Agency
Awardee
Dakota Drug, Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of Losartan-HCTZ 100-25 mg tablets. The contract has a ceiling value of $1,747.92 and a completion date of February 11, 2025. The contract is a firm fixed-price delivery order, which is not associated with a set-aside program. Dakota Drug, Inc. is a key supplier of pharmaceutical products, medical supplies, and healthcare...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $18,462.43 firm fixed-price contract is for the delivery of 4566847986 LOSARTAN-HCTZ 100-25 MG TAB 90S to support U.S. Armed Forces medical operations. The contract has an ultimate completion date of January 7, 2025 and is not a set-aside. Dakota Drug, Inc. is also the prime contractor on a larger $999,999,999.00 Indefinite Delivery Contract...
This federal contract award to Dakota Drug, Inc., a self-certified small disadvantaged business, was issued by the Defense Logistics Agency (DLA) for the delivery of 4566854010 - LOSARTAN-HCTZ 100-25 MG TAB 90S. The contract has a ceiling value of $1,454.42 and a period of performance through January 8, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by Dakota Drug, Inc. with the DLA, valued at $999,999,999.00, which allows the company to provide a comprehensive...
This federal contract award, valued at $14,626.01, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is a Firm Fixed Price Delivery Order for the delivery of 90-count bottles of Losartan-HCTZ 100-12.5 mg tablets. Dakota Drug, Inc. is a key supplier to the DLA Troop Support Medical division, holding a significant single-award Indefinite Delivery Contract (IDC) valued at $999,999,999.00 for the provision of a...
This federal contract award to Dakota Drug, Inc., a self-certified small disadvantaged business, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,807.32 firm fixed-price delivery order is for the supply of Losartan-HCTZ 100-12.5 mg tablets. This order is part of a larger $999,999,999.00 indefinite delivery contract (SPE2DB24D8001) held by Dakota Drug, Inc. under the DLA Troop Support Medical's ECAT Generation V Program, which procures commercial medical equipment,...
This federal contract award, identified as SPE2DB24D8003|SPE2DB25FJTJJ, was issued by the Defense Logistics Agency (DLA) for the delivery of Losartan-HCTZ 100-25 mg tablets in 90-count packages. The $2,777.68 fixed-price delivery order was awarded to Dakota Drug, Inc., a self-certified small disadvantaged business, on November 26, 2024, with a completion date of November 27, 2024. Dakota Drug, Inc. is a key supplier to the DLA Troop Support Medical division, holding a significant $999,999,999.00...
This federal contract award with ID SPE2DB24D8002|SPE2DB25FJMZV was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $6,370.93 firm fixed price delivery order is for the supply of 4566996747 - LOSARTAN-HCTZ 100-25 MG TAB 90S, with a period of performance through January 22, 2025. This award is part of Dakota Drug, Inc.'s larger $999,999,999.00 Indefinite Delivery Contract SPE2DB24D8001 under the DLA Troop Support Medical's ECAT...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $7,663.14, is for the delivery of DIOVAN HCT 320-25 MG TABLET 90S, a prescription medication. The contract has a firm fixed price and an ultimate completion date of May 13, 2024. Dakota Drug, Inc. is a key supplier of pharmaceutical products, medical supplies, and healthcare equipment to the U.S. federal government,...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract to Dakota Drug, Inc., a self-certified small disadvantaged business, to provide DIOVAN HCT 160-25 MG TABLET 90S. The contract, valued at $3,570.23, has an ultimate completion date of October 24, 2024 and is part of the DLA Troop Support Medical's ECAT Generation V Program, a large Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that allows Dakota Drug, Inc. to deliver a comprehensive range...
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed-price delivery order contract valued at $3,351.99 to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the provision of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. This award is part of Dakota Drug, Inc.'s broader Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, which allows the company to supply a range of pharmaceutical products, medical supplies,...